# Top 50 Biotechnology VC (Venture Capital) Funds in Sweden in May 2026

## Sciety
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 14
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Pharmaceutical

Whether you are an investor seeking impactful returns or an entrepreneur looking to take your business to the next level, Sciety is your go-to partner. Join Sciety Venture Partners to invest in the most promising life science companies in the Nordics or get in touch to learn how we can help to turn your life science or health tech innovation into a thriving business.

## Chalmers Ventures AB
- Type: VC Fund
- Location: Göteborg, Vastra Gotaland, Sweden
- Relevant deals: 12
- Stages: Pre-Seed, Seed
- Focus: Software, Energy, Health Care

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

## Industrifonden
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 10
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Information Technology

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

## Almi Invest
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 8
- Stages: Seed, Pre-Seed
- Focus: Software, Health Care, Information Technology

ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion.
Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.

## Navigare Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 5
- Stages: Seed, Pre-Seed, Series A
- Focus: Biotechnology, Energy, Health Care

Welcome to Navigare Ventures. We invest in transformational early-stage companies at the frontier of science and technology.

## Karolinska
- Type: VC Fund
- Location: Solna, Stockholms Lan, Sweden
- Relevant deals: 5
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

## Norrsken VC
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Food and Beverage, Health Care

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

## SEB Venture Capital
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Software, Information Technology, Financial Services

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

## Inventure
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, Information Technology, Health Care

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

## Crowberry Capital
- Type: VC Fund
- Location: Reykjavík, Gullbringusysla, Iceland
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Gaming, Information Technology

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

## LIU Invest
- Type: VC Fund
- Location: Linköping, Ostergotlands Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Information Technology, Health Care

LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.

## Segulah Medical Acceleration
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Series D
- Focus: Health Care, Biotechnology, Medical Device

Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## Nina Capital
- Type: VC Fund
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Artificial Intelligence, Medical

We deploy early stage capital to fuel the growth of need-driven health technology companies.

## Hadean Ventures
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Pharmaceutical

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

## BackingMinds
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Internet, Health Care, Medical Device

We help great minds unleash their full potential!

## Noaber
- Type: VC Fund
- Location: Lunteren, Gelderland, The Netherlands
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Health Care, Medical, Fitness

Noaber Ventures invests in initiatives that bring social transformations using information technology.

## Almi Invest GreenTech
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Waste Management, Chemical, Recycling

Almi Invest GreenTech is a venture capital company and an active start-up investor.

## Boehringer Ingelheim Venture Fund
- Type: VC Fund
- Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

## Irrus Investments
- Type: VC Fund
- Location: Limerick, Limerick, Ireland
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Medical Device

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

## Idinvest Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Biotechnology, Software, Health Care

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

## Nxt2b
- Type: VC Fund
- Location: Uppsala, Uppsala Lan, Sweden
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Biotechnology, Health Diagnostics

Nxt2b is a venture capital company focused on investments in healthcare, pharmaceuticals companies, and medical devices.

## Kurma Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

## KTH Holding
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, Biotechnology

KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.

## Norrlandsfonden
- Type: VC Fund
- Location: Luleå, Norrbottens Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Information Technology, Software, Pharmaceutical

Norrlandsfonden, a trust fund, develops companies across all industries from production industry and tourism to IT and biotechnology.

## Ysios Capital
- Type: VC Fund
- Location: San Sebastian, Pais Vasco, Spain
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

## Partnerinvest Norr
- Type: VC Fund
- Location: Piteå, Norrbottens Lan, Sweden
- Relevant deals: 1
- Stages: Series A, Corporate Round
- Focus: Online Portals, Apps, Biotechnology

Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors.
Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.


## Flerie Invest
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

## TVM Capital
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 1
- Stages: Series B, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

TVM Capital Group is an affiliation of globally acting venture capital and private equity firms with an operating track record of more than 30 years.

## Forbion Capital Partners
- Type: VC Fund
- Location: Naarden, Noord-Holland, The Netherlands
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Impacting the future of medicine.

## Voima Ventures
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Health Care, Software

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

## Teknoinvest
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Health Care, Biotechnology, Medical

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.

## Kale United
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Food and Beverage, Food Processing, Biotechnology

Kale United offers a portfolio of over 75+ plant-based game changers

## Glass Wall Syndicate
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series C
- Focus: Biotechnology, Health Care, Food and Beverage

Glass Wall Syndicate invests in companies and products that will make a difference in the lives of animals, people, and the planet. It helps grow companies in this space by providing them with capital, resources, mentorship, and other forms of support.The firm is consists of a group of venture capitalists, foundations, trusts, non-profits, andindividual investors who share a similar investment thesis and want to accelerate mainstream adoption of products and services that will make a difference in the lives of animals, people and that are better for the planet.

## European Investment Bank
- Type: VC Fund
- Location: Luxembourg, Luxembourg, Luxembourg
- Relevant deals: 1
- Stages: Debt Financing, Post-IPO Debt
- Focus: Biotechnology, Health Care, Software

European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.

## CBC Investment Group
- Type: VC Fund
- Location: Gothenburg, Vastra Gotaland, Sweden
- Relevant deals: 1
- Stages: Seed, Series B
- Focus: Biotechnology, Software, SaaS

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

## Porte Monnaie
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Health Care, Biotechnology, Science and Engineering

Porte Monnaie is an early and active investor for startup companies and passive investors in listed companies with growth potential.
Porte-Monnaie's mission is to invest in Swedish companies.

## Länsförsäkringar
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed
- Focus: Manufacturing, Apps, Mobile

Länsförsäkringar is a Swedish group of public insurance companies.

## Crosslight Partners
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Biotechnology, B2B, Medical

Crosslight Partners is a growth equity firm. The firm invests in the environment, healthcare, impact, and technology sectors across Europe.

## Additio Investment Group
- Type: VC Fund
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Biotechnology, Medical

Value creation for Healthcare & Life Sciences Ventures through capital, expertise, international network.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## PULS
- Type: VC Fund
- Location: Saint Charles, Illinois, United States
- Relevant deals: 1
- Focus: Biopharma, Health Care, Biotechnology

PULS is specialized on DIN rail power supplies for industrial applications. We set standards in terms of efficiency, reliability, size and life time.

## Falkenbergs Sparbanks Foundation
- Type: VC Fund
- Relevant deals: 1
- Focus: Biotechnology, Manufacturing, Food Processing

Falkenbergs Sparbanks Foundation

## Innovations Kapital
- Type: VC Fund
- Location: Göteborg, Vastra Gotaland, Sweden
- Relevant deals: 1
- Stages: Series B, Series C
- Focus: Biotechnology, Health Care, Software

InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.

## FBG Invest
- Type: VC Fund
- Relevant deals: 1
- Focus: Biotechnology, Manufacturing, Food Processing

FBG Invest

## TPG Growth
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series C, Private Equity, Series B
- Focus: Health Care, Biotechnology, Software

A leader in the alternative asset space, TPG was built for a distinctive approach, managing assets through a principled focus on innovation.

## Plantbase Foundation
- Type: VC Fund
- Relevant deals: 1
- Focus: Biotechnology, Manufacturing, Food Processing

Plantbase Foundation

## Bonnier Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Digital Media, Software

Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies and funds of various sizes.

## Joyance Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Wellness

Joyance Partners is the first venture fund supporting companies that deliver Delightful Moments derived from science - a new, transformative cycle of human experience that we see as one of the greatest investment opportunities in decades.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co